Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers (DELOGAST)
Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers
Sponsor: University Hospital, Lille
This NA trial investigates Gastric Adenocarcinoma and Oesophageal Carcinoma and is currently completed. University Hospital, Lille leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2025 — Jan 2026 [monthly]
Unknown NA
-
Jun 2025 — Sep 2025 [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Nov 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Lille
- University of Lille Nord de France
For direct contact, visit the study record on ClinicalTrials.gov .